ArticleAmerican journal of hematology2022

Checkpoint inhibitor immunotherapy during pregnancy for relapsed-refractory Hodgkin lymphoma.

Andrew M Evens et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.